Insider Buying: Corvus Pharmaceuticals (NASDAQ:CRVS) Insider Acquires 1,003 Shares of Stock
MarketBeat
Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS - Get Free Report) insider Jeffrey Arcara acquired 1,003 shares of the firm's stock in a transaction that occurred on Friday, November 13th. The stock was purchased at an average price of $10.54 per share, with a total value of $10,571.62. Following the completion of the acquisition, the insider directly owned 4,500 shares of the company's stock, valued at $47,430. This represents a 28.68% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website.
NASDAQ:CRVS